Cardiomyopathy, Dilated Clinical Trial
Official title:
Early Treatment With Candesartan vs Placebo in Asymptomatic Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)"
Prospective, multicenter, randomized, placebo-controlled, double-blind clinical trial to evaluate safety and efficacy of candesartan in the prevention of the development of Dilated Cardiomyopathy (DCM) in genetic carriers of a DCM-causing variant without disease expression (asymptomatic)
Prospective, multicenter, randomized, placebo-controlled, double-blind clinical trial to evaluate safety and efficacy of early administration of candesartan in the prevention of the development of Dilated Cardiomyopathy (DCM) in genetic carriers of a DCM-causing variant without disease expression (asymptomatic). Randomization will be 1:1 and patients are allocated to candesartan or matching placebo. Patients will be followed for a 3 years period and efficacy will be demonstrated if candesartan (compared to placebo) prevents either a significant Left ventricular ejection fraction (LVEF) decline of ≥10%, or a ventricular dilatation (left ventricular end-diastolic volume, LVEDV) increase of ≥10% within a 3-years period of follow-up ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03560167 -
Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation
|
N/A | |
Terminated |
NCT00624520 -
Mental Stress Reduction in Defibrillator Patients
|
Phase 3 | |
Completed |
NCT00549861 -
Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR
|
N/A | |
Terminated |
NCT04222101 -
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
|
N/A | |
Not yet recruiting |
NCT02517814 -
Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy
|
N/A | |
Completed |
NCT01940081 -
The Leiden Nonischemic Cardiomyopathy Study
|
||
Completed |
NCT01391507 -
Pilot Study of COR-1 in Heart Failure
|
Phase 2 | |
Completed |
NCT01181414 -
Spanish Atrial Fibrillation And Resynchronization Study
|
Phase 4 | |
Not yet recruiting |
NCT06091475 -
Therapy to Maintain Remission in Dilated Cardiomyopathy
|
N/A | |
Recruiting |
NCT03340675 -
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
|
Phase 2 | |
Recruiting |
NCT05981092 -
A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease)
|
||
Not yet recruiting |
NCT06039072 -
Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
|
||
Recruiting |
NCT03910725 -
Electrophysiological Phenotyping Of Patients at Risk of Ventricular Arrhythmia and Sudden Cardiac Death
|
||
Terminated |
NCT01478087 -
Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)
|
N/A | |
Recruiting |
NCT00221780 -
Role of Left Ventricular Pacing Site
|
N/A | |
Terminated |
NCT02958098 -
My Research Legacy Pilot Study
|
||
Completed |
NCT00123071 -
Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network
|
N/A | |
Completed |
NCT00284713 -
Progenitor Cell Therapy in Dilative Cardiomyopathy
|
Phase 1/Phase 2 | |
Completed |
NCT01260402 -
Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.
|
N/A | |
Completed |
NCT04192214 -
The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor
|
Phase 2 |